Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Biohit Oyj stock

BIOBV.HE
FI0009005482

Price

2.46 EUR
Today +/-
+0.08 EUR
Today %
+3.31 %
P

Biohit Oyj stock price

EUR
%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Biohit Oyj stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Biohit Oyj stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Biohit Oyj stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Biohit Oyj's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Biohit Oyj Stock Price History

DateBiohit Oyj Price
11/7/20242.46 EUR
11/6/20242.38 EUR
11/5/20242.39 EUR
11/4/20242.35 EUR
11/1/20242.44 EUR
10/31/20242.35 EUR
10/30/20242.43 EUR
10/29/20242.46 EUR
10/28/20242.50 EUR
10/25/20242.42 EUR
10/24/20242.46 EUR
10/23/20242.45 EUR
10/22/20242.53 EUR
10/21/20242.47 EUR
10/18/20242.35 EUR
10/17/20242.25 EUR
10/16/20242.35 EUR
10/15/20242.32 EUR
10/14/20242.35 EUR
10/11/20242.35 EUR
10/10/20242.33 EUR

Biohit Oyj Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Biohit Oyj, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Biohit Oyj from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Biohit Oyj’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Biohit Oyj. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Biohit Oyj’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Biohit Oyj’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Biohit Oyj’s growth potential.

Biohit Oyj Revenue, EBIT and net profit per share

DateBiohit Oyj RevenueBiohit Oyj EBITBiohit Oyj Net Income
2027e22.96 M EUR3.41 M EUR2.15 M EUR
2026e20.6 M EUR3.09 M EUR2.01 M EUR
2025e17.51 M EUR2.06 M EUR1.63 M EUR
2024e15.45 M EUR2.06 M EUR1.63 M EUR
202313.08 M EUR1.83 M EUR1.85 M EUR
202210.95 M EUR1.13 M EUR601,000 EUR
20219.36 M EUR-1.48 M EUR-1.5 M EUR
20207.12 M EUR-3.17 M EUR-3.31 M EUR
201910.05 M EUR-1.41 M EUR-1.42 M EUR
20189.93 M EUR-1.97 M EUR-2.14 M EUR
20178.98 M EUR-1.63 M EUR6.14 M EUR
20168.2 M EUR-3.16 M EUR-3.3 M EUR
20156.05 M EUR-2.83 M EUR-2.92 M EUR
20144.36 M EUR-4.5 M EUR-1.16 M EUR
20133.45 M EUR-5.86 M EUR-5.92 M EUR
20122.05 M EUR-4.59 M EUR-3.66 M EUR
20112.1 M EUR-2.21 M EUR37.71 M EUR
201040.26 M EUR510,000 EUR60,000 EUR
200935.53 M EUR1.19 M EUR390,000 EUR
200835.27 M EUR1.31 M EUR900,000 EUR
200732.83 M EUR-480,000 EUR-1.5 M EUR
200631.44 M EUR-140,000 EUR-840,000 EUR
200528.73 M EUR-30,000 EUR-230,000 EUR
200426.88 M EUR-170,000 EUR-590,000 EUR

Biohit Oyj Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M EUR)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M EUR)EBIT (M EUR)EBIT MARGIN (%)NET INCOME (M EUR)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e
16202426252626283132353540223468891079101315172022
-25.0020.008.33-3.854.00-7.6910.713.239.38-14.29-95.00-50.0033.3350.0033.33-12.5011.11-30.0028.5711.1130.0015.3813.3317.6510.00
75.0075.0070.8376.9280.0080.7780.7782.1480.6581.2580.0080.0080.0050.00-33.3350.0050.0050.0062.5066.6760.0042.8655.5670.0061.54----
1215172020212123252628283210123456635780000
1100-100000110-2-4-5-4-2-3-1-1-1-3-1112233
6.255.00---4.00-----2.862.86--100.00-200.00-166.67-100.00-33.33-37.50-12.50-11.11-10.00-42.86-11.1110.007.6913.3311.7615.0013.64
1000-10000-100037-3-5-1-2-36-2-1-3-1011122
---------------108.1166.67-80.00100.0050.00-300.00-133.33-50.00200.00-66.67----100.00-
6.2612.0712.5712.6412.8312.9412.9413.112.9412.9412.9413.8413.8413.6213.6213.9213.9414.2814.6914.9414.915.0115.0515.0515.0515.130000
------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Biohit Oyj Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Biohit Oyj is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M EUR)RECEIVABLES (M EUR)OTHER REC. (M EUR)INVENTORIES (M EUR)OTHER CURRENT LIAB. (M EUR)CURRENT ASSETS (M EUR)TANGIBLE ASSETS (M EUR)LONG-T. INVEST. (M EUR)LONG-T. REC. (M EUR)INTANGIBLE ASSETS (M EUR)GOODWILL (M EUR)OTHER NON-CURRENT ASSETS (M EUR)NON-CURRENT ASSETS (M EUR)TOTAL ASSETS (M EUR)LIABILITIESCOMMON STOCK (M EUR)ADDITIONAL PAID-IN CAPITAL (M EUR)RETAINED EARNINGS (M EUR)OTHER EQUITY (M EUR)UNREAL. GAINS/LOSSES (M EUR)EQUITY (M EUR)LIABILITIES (M EUR)PROVISIONS (M EUR)OTHER SHORT-TERM LIAB. (M EUR)SHORT-TERM DEBTS (M EUR)LONG-TERM DEBT PORTION (M EUR)SHORT-TERM REC. (M EUR)LONG-T. LIAB. (M EUR)DEFERRED TAXES (k EUR)OTHER LIAB. (M EUR)LONG-T. LIABILITIES (M EUR)DEBT (M EUR)TOTAL CAPITAL (M EUR)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                   
1.137.223.022.461.371.051.34.151.712.031.791.982.1657.9230.4815.7110.427.247.738.719.389.326.085.526.236.81
4.294.794.434.494.645.074.615.546.045.535.866.016.594.350.310.550.48100000000
0.751.130.780.350.280.350.370.320.310.410.340.330.541.30.1100.04000000000
2.462.373.794.253.64.073.574.585.775.625.775.145.240.320.440.650.820.640.860.680.830.990.90.750.920.89
0.130.361.252.011.741.451.210.270.320.440.60.550.650.330.187.16000-0000-000
8.7615.8713.2713.5611.6311.9911.0614.8614.1514.0314.3614.0115.1864.2231.5224.0711.768.888.69.3910.210.316.986.267.157.7
1.722.185.656.376.436.26.596.866.867.26.456.466.530.250.430.510.860.780.720.710.560.670.640.420.990.77
0.210.210.210.220.120.010.010.020.010.010.010.010.016.837.82200.60.38000.060.060.060.060.12
00000000000000000000000000
1.731.340.91.181.191.041.181.421.581.491.642.353.180.310.221.731.611.41.26.765.053.41.760.140.040.18
6.015.114.623.673.052.642.362.642.642.642.642.642.640000000000000
00000002.072.11.952.011.941.85-0.14000.030.080.110.070.060.030.020.010.020.02
9.678.8411.3811.4410.799.8910.1413.0113.1913.2912.7513.414.217.258.474.242.52.852.47.545.664.162.480.631.111.09
18.4324.7124.652522.4221.8821.227.8727.3427.3227.1127.4129.3971.4739.9928.3114.2611.731116.9415.8614.479.466.898.268.79
                                                   
1.732.092.152.152.22.22.22.22.22.22.22.22.22.322.322.352.352.352.352.352.352.352.352.352.352.35
10.2914.1714.9114.9115.4315.4313.1113.0212.412.412.412.412.4114.293.232.751.882.374.354.784.935.145.145.145.145.21
-4.920-0.62-0.83-2.8-3.59-1.87-1.09-1.31-2.81-1.92-1.53-1.4736.2429.9517.358.445.584.1510.268.767.182.470.981.783.84
1.391.451.131.241.241.241.240.120.120.05-0.19-0.32-0.13000.010.010.01-0.09-0.14-0.14-0.08-0.09-0.08-0.11-0.09
0000000000000000000000-1.17-1.09-1.7-1.87
8.4917.7117.5717.4716.0715.2814.6814.2513.4111.8412.4912.7513.0152.8535.522.4612.6810.3110.7517.2415.8914.588.77.37.469.43
0.931.290.971.250.841.291.1400000000.360.340.530.330.980.410.520.870.610.580.680.47
1.31.061.062.321.171.41.3402.1400000000000000000
0.480.921.190.880.820.510.574.172.965.314.724.896.0613.633.774.920.840.790.840.851.031.281.071.511.932.32
000000000003.9903.85000000000000
1.890.790.880.80.80.930.960.91.380.871.11.130.921.060.380.380.260.1300.020.020.230.260.070.260.28
4.64.064.15.253.634.134.015.076.486.185.8210.016.9818.544.515.641.631.241.821.281.572.381.942.152.863.06
4.842.862.792.082.542.32.47.266.328.267.993.858.550.09000000.060.040.060.130.160.690.43
020110100100100909010080000002102001764123113803523222
0.460.01000001.181.010.980.80.790.86000000.010000.010.010.010.01
5.32.892.92.182.642.42.498.537.439.328.794.649.410.0900.210.20.180.420.370.430.420.130.160.70.44
9.96.9577.436.276.536.513.613.9115.514.6114.6516.3918.634.515.851.831.422.241.651.992.792.072.313.563.49
18.3924.6624.5724.922.3421.8121.1827.8527.3227.3427.127.429.471.4840.0128.3114.5111.7312.9918.917.8917.3710.789.6111.0112.92
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Biohit Oyj provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Biohit Oyj's financial health and stability.

Assets

Biohit Oyj's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Biohit Oyj must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Biohit Oyj after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Biohit Oyj's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M EUR)DEPRECIATION (M EUR)DEFERRED TAXES (M EUR)CHANGES IN WORKING CAPITAL (M EUR)NON-CASH ITEM (k EUR)PAID INTEREST (k EUR)PAID TAXES (M EUR)NET CASH FLOW FROM OPERATING ACTIVITIES (M EUR)CAPITAL EXPENDITURES (M EUR)CASH FLOW FROM INVESTING ACTIVITIES (M EUR)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M EUR)INTEREST INCOME AND EXPENSES (M EUR)NET DEBT CHANGE (M EUR)NET CHANGE IN EQUITY (M EUR)CASH FLOW FROM FINANCING ACTIVITIES (M EUR)CASH FLOW FROM OTHER FINANCING ACTIVITIES (EUR)TOTAL DIVIDENDS PAID (M EUR)NET CHANGE IN CASH FLOW (M EUR)FREE CASH FLOW (M EUR)SHARE-BASED COMPENSATION (M EUR)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0000-10000-110037-3-5-1-2-36-2-1-3-101
12222211111114000001121100
00000000000000000000000000
0-1-10-100-1-10-1002-40000000100-1
1,000000000000000-39,00001,000-2,00000-8,000000000
1,0000000000000000000000000000
00001000000000400000000000
21010020011214-8-4-3-3-20000010
-1-1-4-2-1-1-2-1-1-2-1-2-1-4000000000000
-1-1-5-1-1-1-2-50-20-1-143-201412221000000
0000000-32000047-201513321000000
00000000000000000000000000
-1-300000301000-3-400000000000
18000000000002000000000000
0500100301000-2-18-9-9000000000
--------------------------
00000000000000-13-100000000000
06-40-10000000046-4700000000010
1.350.59-3.92-0.29-2.18-0.280.11-1.07-1.59-1.02-0.040.780.180.89-9.17-4.92-3.84-3.37-2.55-1.11-0.110.04-0.04-0.481.790.7
00000000000000000000000000

Biohit Oyj stock margins

The Biohit Oyj margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Biohit Oyj. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Biohit Oyj.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Biohit Oyj's sales revenue. A higher gross margin percentage indicates that the Biohit Oyj retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Biohit Oyj's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Biohit Oyj's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Biohit Oyj's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Biohit Oyj. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Biohit Oyj's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Biohit Oyj Margin History

Biohit Oyj Gross marginBiohit Oyj Profit marginBiohit Oyj EBIT marginBiohit Oyj Profit margin
2027e64.73 %14.85 %9.35 %
2026e64.73 %15 %9.76 %
2025e64.73 %11.76 %9.33 %
2024e64.73 %13.33 %10.58 %
202364.73 %13.96 %14.16 %
202264.94 %10.31 %5.49 %
202163.19 %-15.81 %-16.02 %
202055.57 %-44.56 %-46.51 %
201966.33 %-14.05 %-14.1 %
201864.86 %-19.79 %-21.58 %
201762.81 %-18.12 %68.37 %
201651.31 %-38.54 %-40.21 %
201552.82 %-46.77 %-48.21 %
201455.9 %-103.21 %-26.61 %
201350.72 %-169.86 %-171.59 %
201235.61 %-223.9 %-178.54 %
201153.81 %-105.24 %1,795.71 %
201079.63 %1.27 %0.15 %
200981 %3.35 %1.1 %
200880.24 %3.71 %2.55 %
200779.59 %-1.46 %-4.57 %
200679.55 %-0.45 %-2.67 %
200580.19 %-0.1 %-0.8 %
200479.24 %-0.63 %-2.19 %

Biohit Oyj Stock Sales Revenue, EBIT, Earnings per Share

The Biohit Oyj earnings per share therefore indicates how much revenue Biohit Oyj has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Biohit Oyj earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Biohit Oyj's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Biohit Oyj’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Biohit Oyj's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Biohit Oyj Revenue, EBIT and net profit per share

DateBiohit Oyj Sales per ShareBiohit Oyj EBIT per shareBiohit Oyj Earnings per Share
2027e1.88 EUR0 EUR0.18 EUR
2026e1.69 EUR0 EUR0.16 EUR
2025e1.43 EUR0 EUR0.13 EUR
2024e1.27 EUR0 EUR0.13 EUR
20230.86 EUR0.12 EUR0.12 EUR
20220.73 EUR0.08 EUR0.04 EUR
20210.62 EUR-0.1 EUR-0.1 EUR
20200.47 EUR-0.21 EUR-0.22 EUR
20190.67 EUR-0.09 EUR-0.09 EUR
20180.67 EUR-0.13 EUR-0.14 EUR
20170.6 EUR-0.11 EUR0.41 EUR
20160.56 EUR-0.22 EUR-0.22 EUR
20150.42 EUR-0.2 EUR-0.2 EUR
20140.31 EUR-0.32 EUR-0.08 EUR
20130.25 EUR-0.42 EUR-0.43 EUR
20120.15 EUR-0.34 EUR-0.27 EUR
20110.15 EUR-0.16 EUR2.77 EUR
20102.91 EUR0.04 EUR0 EUR
20092.57 EUR0.09 EUR0.03 EUR
20082.73 EUR0.1 EUR0.07 EUR
20072.54 EUR-0.04 EUR-0.12 EUR
20062.43 EUR-0.01 EUR-0.06 EUR
20052.19 EUR-0 EUR-0.02 EUR
20042.08 EUR-0.01 EUR-0.05 EUR

Biohit Oyj business model

Biohit Oyj is one of the most popular companies on Eulerpool.com.

Biohit Oyj Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Biohit Oyj historical P/E ratio, EBIT multiple, and P/S ratio

Biohit Oyj shares outstanding

The number of shares was Biohit Oyj in 2023 — This indicates how many shares 15.127 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Biohit Oyj earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Biohit Oyj's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Biohit Oyj’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Biohit Oyj's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Biohit Oyj dividend history and estimates

In 2023, Biohit Oyj paid a dividend amounting to 0 EUR. Dividend means that Biohit Oyj distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Biohit Oyj provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Biohit Oyj’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Biohit Oyj's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Biohit Oyj Dividend History

DateBiohit Oyj Dividend
20140.72 EUR
20130.24 EUR
20120.8 EUR

Biohit Oyj dividend payout ratio

In 2023, Biohit Oyj had a payout ratio of 0%. The payout ratio indicates the percentage of the company's profits that Biohit Oyj distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Biohit Oyj represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Biohit Oyj could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Biohit Oyj's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Biohit Oyj Payout Ratio History

DateBiohit Oyj Payout ratio
2027e0 %
2026e0 %
2025e0 %
2024e0 %
20230 %
20220 %
20210 %
20200 %
20190 %
20180 %
20170 %
20160 %
20150 %
2014-904.25 %
2013-55.12 %
2012-296.3 %
20110 %
20100 %
20090 %
20080 %
20070 %
20060 %
20050 %
20040 %

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Biohit Oyj.

Biohit Oyj latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20110.02 EUR0.03 EUR (45.63 %)2011 Q3
3/31/20080 EUR-0.03 EUR (0 %)2008 Q1
12/31/20070 EUR-0.03 EUR (0 %)2007 Q4
9/30/20070.01 EUR-0.02 EUR (-294.17 %)2007 Q3
6/30/20070.02 EUR-0.06 EUR (-391.26 %)2007 Q2
3/31/20070.01 EUR0 EUR (-100 %)2007 Q1
12/31/2006-0.01 EUR-0.01 EUR (32.04 %)2006 Q4
9/30/2006-0.03 EUR0 EUR (100 %)2006 Q3
6/30/20060.01 EUR-0.03 EUR (-391.26 %)2006 Q2
3/31/20060.01 EUR-0.02 EUR (-245.63 %)2006 Q1
1
2

Biohit Oyj shareholders

%
Name
Stocks
Change
Date
33.55220 % Biohit Healthcare Hefei CoLtd4,095,41501/31/2024
2.19534 % Härkönen (Matti)267,96501/31/2024
1.06504 % Interlab Oy130,00001/31/2024
0.70880 % Virkkala (Juha Jarkko)86,5175,5171/31/2024
0.69927 % Suovaniemi (Vesa Jukka Markku)85,35301/31/2024
0.63616 % Syrjälä (Pekka)77,65001/31/2024
0.62756 % Jaakkola (Sami Juhani)76,60001/31/2024
0.57348 % Ruusila (Ari Tapio)70,00001/31/2024
0.54942 % Korkiamaki (Heikki Antero)67,06367,0631/31/2024
0.52433 % Alkku (Jari Pekka)64,00001/31/2024
1
2
3

Biohit Oyj Executives and Management Board

Prof. Osmo Suovaniemi(78)
Biohit Oyj Chairman of the Board, Deputy Chief Executive Officer
Compensation 16,000 EUR
Mr. Franco Aiolfi(70)
Biohit Oyj Director, Managing Director of Biohit Healthcare S.r.l. (since 2013)
Compensation 15,000 EUR
Mr. Eero Lehti(73)
Biohit Oyj Independent Director
Compensation 15,000 EUR
Mr. Jussi Hahtela(49)
Biohit Oyj Chief Executive Officer, Member of the Management Board
Mr. Jussi Sorvo
Biohit Oyj Chief Financial Officer, Member of the Management Board
1
2
3

Biohit Oyj Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Oriola Corp B Stock
Oriola Corp B
SupplierCustomer0,42-0,20-0,640,31-0,26-0,10
Eurobio-Scientific Stock
Eurobio-Scientific
SupplierCustomer0,41-0,510,450,60-0,24-0,47
AddLife B Stock
AddLife B
SupplierCustomer0,26-0,020,350,400,51-0,36
Daiichi Sankyo Stock
Daiichi Sankyo
SupplierCustomer0,24-0,52-0,90-0,64-0,620,09
Kureha Stock
Kureha
SupplierCustomer0,200,46-0,67-0,70-0,80-0,67
Grand Pharmaceutical Group Stock
Grand Pharmaceutical Group
SupplierCustomer0,120,760,830,800,740,44
Nuvo Pharmaceuticals Stock
Nuvo Pharmaceuticals
SupplierCustomer-0,200,610,690,670,31
Bio-Techne Stock
Bio-Techne
SupplierCustomer-0,550,320,780,550,71-0,29
1

Most common questions regarding Biohit Oyj

What is the P/E ratio of Biohit Oyj 2024?

The Biohit Oyj P/E ratio is 22.77.

What is the P/S ratio of Biohit Oyj 2024?

The Biohit Oyj P/S ratio is 2.41.

What is the Quality Investing of Biohit Oyj?

The Quality Investing for Biohit Oyj is 6/10.

What is the revenue of Biohit Oyj 2024?

The expected Biohit Oyj revenue is 15.45 M EUR.

How high is the profit of Biohit Oyj 2024?

The expected Biohit Oyj profit is 1.63 M EUR.

What is the business model of Biohit Oyj

No history available for Biohit Oyj.

What is the Biohit Oyj dividend?

Biohit Oyj pays a dividend of 0 EUR distributed over payouts per year.

How often does Biohit Oyj pay dividends?

The dividend cannot currently be calculated for Biohit Oyj or the company does not pay out a dividend.

What is the Biohit Oyj ISIN?

The ISIN of Biohit Oyj is FI0009005482.

What is the Biohit Oyj ticker?

The ticker of Biohit Oyj is BIOBV.HE.

How much dividend does Biohit Oyj pay?

Over the past 12 months, Biohit Oyj paid a dividend of 0.72 EUR . This corresponds to a dividend yield of about 29.41 %. For the coming 12 months, Biohit Oyj is expected to pay a dividend of 0 EUR.

What is the dividend yield of Biohit Oyj?

The current dividend yield of Biohit Oyj is 29.41 %.

When does Biohit Oyj pay dividends?

Biohit Oyj pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biohit Oyj?

Biohit Oyj paid dividends every year for the past 0 years.

What is the dividend of Biohit Oyj?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biohit Oyj located?

Biohit Oyj is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biohit Oyj kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biohit Oyj from 4/28/2014 amounting to 0.723 EUR, you needed to have the stock in your portfolio before the ex-date on 4/15/2014.

When did Biohit Oyj pay the last dividend?

The last dividend was paid out on 4/28/2014.

What was the dividend of Biohit Oyj in the year 2023?

In the year 2023, Biohit Oyj distributed 0 EUR as dividends.

In which currency does Biohit Oyj pay out the dividend?

The dividends of Biohit Oyj are distributed in EUR.

All fundamentals about Biohit Oyj

Our stock analysis for Biohit Oyj Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biohit Oyj Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.